Overview

Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study aims to compare efficacy and safety of tacrolimus/methotrexate with cyclosporine/methotrexate for graft versus host disease prophylaxis in paediatric allogeneic hematopoietic stem cell transplantation patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Cyclosporine
Cyclosporins
Methotrexate
Tacrolimus